Literature DB >> 1660103

GABAergic drugs and conflict behavior in the rat: lack of similarities with the actions of benzodiazepines.

A Agmo1, R Pruneda, M Guzmán, M Gutiérrez.   

Abstract

Effects of drugs which enhance or reduce GABAergic neurotransmission upon conflict behavior were evaluated with a modified Vogel procedure which was shown to be insensitive to variations in motivation to drink and to the analgesic effects of morphine. In addition, the effects of these drugs on ambulatory activity and motor execution were quantified. For comparison, the benzodiazepines diazepam and chlordiazepoxide were used. Anticonflict actions of diazepam were obtained with a shock current of 0.25 mA but not with 0.05 or 0.5 mA, whereas the proconflict effect of FG7142 was obtained with 0.05 mA but not with higher currents. Diazepam and chlordiazepoxide had anxiolytic effect in a dose similar to that required to reduce ambulatory activity, but below that needed to affect motor execution. At doses high enough to impair motor execution, anticonflict effects were considerable. The GABA-A receptor agonist THIP and the GABA-B receptor agonist baclofen lacked effect on conflict behavior in moderate doses, which reduced ambulatory activity. In doses which produced motor deficiencies these drugs reduced licking both in the conflict test and when tested without shock administration. The effects of the GABA transaminase inhibitors gamma-acetylene GABA and sodium valproate were similar to those of the receptor agonists. The GABA reuptake inhibitor SKF 100330A produced anticonflict effect in a dose below that needed to reduce ambulatory activity, but lacked effect on conflict behavior in higher doses. The GABA antagonist picrotoxin, and the GABA synthesis inhibitors 4-deoxypyridoxine and isoniazide, reduced licking both in the absence and presence of shock, and affected motor functions in the same doses. Bicuculline, at the doses used, had no behavioral effects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660103     DOI: 10.1007/bf00183006

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  45 in total

1.  The effect of 4-amino hex-5-ynoic acid (gamma-acetylenic GABA, gammma-ethynyl GABA) a catalytic inhibitor of GABA transaminase, on brain GABA metabolism in vivo.

Authors:  M J Jung; B Lippert; B W Metcalf; P J Schechter; P Böhlen; A Sjoerdsma
Journal:  J Neurochem       Date:  1977-04       Impact factor: 5.372

Review 2.  Effects of drugs on punished behavior: pre-clinical test for anxiolytics.

Authors:  G T Pollard; J L Howard
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

3.  Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system.

Authors:  J Scheel-Krüger
Journal:  Acta Neurol Scand Suppl       Date:  1986

4.  Analgesic profile of tranquillizers in multiple screening tests in mice.

Authors:  C P Weller; I Ibrahim; F G Sulman
Journal:  Arch Int Pharmacodyn Ther       Date:  1968-11

5.  Drug-induced changes in GABA content of nerve endings in 11 rat brain regions. Correlation to pharmacological effects.

Authors:  W Löscher; M Vetter
Journal:  Neurosci Lett       Date:  1984-06-29       Impact factor: 3.046

6.  A water lick conflict paradigm using drug experienced rats.

Authors:  E N Petersen; J B Lassen
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 7.  Drug interactions at the GABA receptor-ionophore complex.

Authors:  R W Olsen
Journal:  Annu Rev Pharmacol Toxicol       Date:  1982       Impact factor: 13.820

8.  Variation in behavioral response to baclofen: correlation with benzodiazepine binding sites in mouse forebrain.

Authors:  L Rägo; R A Kiivet; J Harro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

Review 9.  GABAergic synapses. Supramolecular organization and biochemical regulation.

Authors:  A Guidotti; M G Corda; B C Wise; F Vaccarino; E Costa
Journal:  Neuropharmacology       Date:  1983-12       Impact factor: 5.250

10.  The locomotor-reducing effects of GABAergic drugs do not depend on the GABAA receptor.

Authors:  A Agmo; M Giordano
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more
  9 in total

1.  Effects of diazepam on conflict behaviour and on plasma corticosterone levels in male and female rats.

Authors:  D Pericić; N Pivac
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-03       Impact factor: 3.000

2.  Interactions between dopamine and GABA in the control of ambulatory activity.

Authors:  A Agmo; C Belzung; M Giordano
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  A comparison of chlordiazepoxide, bretazenil, L838,417 and zolpidem in a validated mouse Vogel conflict test.

Authors:  L Mathiasen; N R Mirza
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

4.  A rat model of distractibility: effects of drugs modifying dopaminergic, noradrenergic and GABAergic neurotransmission.

Authors:  A Agmo; C Belzung; C Rodríguez
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

5.  Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase.

Authors:  S F Kash; L H Tecott; C Hodge; S Baekkeskov
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

6.  Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice.

Authors:  Xia Li; Victoria B Risbrough; Chelsea Cates-Gatto; Katarzyna Kaczanowska; M G Finn; Amanda J Roberts; Athina Markou
Journal:  Neuropharmacology       Date:  2013-01-29       Impact factor: 5.250

7.  Deep brain stimulation affects conditioned and unconditioned anxiety in different brain areas.

Authors:  A van Dijk; M Klanker; N van Oorschot; R Post; R Hamelink; M G P Feenstra; D Denys
Journal:  Transl Psychiatry       Date:  2013-07-30       Impact factor: 6.222

8.  Anxiety in mice: a principal component analysis study.

Authors:  Yan Clément; Chantal Joubert; Caroline Kopp; Eve M Lepicard; Patrice Venault; René Misslin; Martine Cadot; Georges Chapouthier
Journal:  Neural Plast       Date:  2007-03-21       Impact factor: 3.599

9.  Pharmacological alterations of anxious behaviour in mice depending on both strain and the behavioural situation.

Authors:  Yan Clément; Anne-Marie Le Guisquet; Patrice Venault; Georges Chapouthier; Catherine Belzung
Journal:  PLoS One       Date:  2009-11-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.